Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (201-210 of 221) with videos related to

Pageof 23
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.
International Journal of Cancer|September 3, 2020
Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnosticsHendrik Bläker, Saskia Haupt, Monika Morak, et al.
Cell|June 19, 2018
Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during TumorigenesisPaul K Ziegler, Julia Bollrath, Charles K Pallangyo, et al.
British Journal of Cancer|February 16, 2024
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implicationNanna Monjé, Mihnea P Dragomir, Bruno V Sinn, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
ADC target profiling in NSCLC: Generalizable AI separates TROP-2 and cMET phenotypesPhilipp Anders, Marvin Sextro, Katja Lingelbach, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
Pathologica|July 8, 2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladderFlorian Viehweger, Natalia Gorbokon, Seyma Büyücek, et al.
Frontiers in Oncology|January 29, 2024
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomasJan H Müller, Henning Plage, Sefer Elezkurtaj, et al.
European Urology|February 21, 2024
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial CancerNicolaus F Debatin, Elena Bady, Tim Mandelkow, et al.
Pageof 23

Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.
International Journal of Cancer|September 3, 2020
Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnosticsHendrik Bläker, Saskia Haupt, Monika Morak, et al.
Cell|June 19, 2018
Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during TumorigenesisPaul K Ziegler, Julia Bollrath, Charles K Pallangyo, et al.
British Journal of Cancer|February 16, 2024
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implicationNanna Monjé, Mihnea P Dragomir, Bruno V Sinn, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
ADC target profiling in NSCLC: Generalizable AI separates TROP-2 and cMET phenotypesPhilipp Anders, Marvin Sextro, Katja Lingelbach, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
Pathologica|July 8, 2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladderFlorian Viehweger, Natalia Gorbokon, Seyma Büyücek, et al.
Frontiers in Oncology|January 29, 2024
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomasJan H Müller, Henning Plage, Sefer Elezkurtaj, et al.
European Urology|February 21, 2024
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial CancerNicolaus F Debatin, Elena Bady, Tim Mandelkow, et al.
Pageof 23